These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. HTLV-I/II infections in Spain. The HTLV-I/II Spanish Study Group. Soriano V, Calderón E, Esparza B, Cilla G, Aguilera A, Gutiérrez M, Tor J, Pujol E, Merino F, Pérez-Trallero E. Int J Epidemiol; 1993 Aug; 22(4):716-9. PubMed ID: 8225748 [Abstract] [Full Text] [Related]
14. Human T-cell lymphotropic virus testing of blood donors in Norway: a cost-effect model. Stigum H, Magnus P, Samdal HH, Nord E. Int J Epidemiol; 2000 Dec; 29(6):1076-84. PubMed ID: 11101551 [Abstract] [Full Text] [Related]
15. Prevalence of antibodies to HTLV-I/II in high-risk patients and blood donors in Denmark. Christiansen CB, Wantzin P, Dickmeiss E. Vox Sang; 1995 Dec; 68(1):63-4. PubMed ID: 7725675 [No Abstract] [Full Text] [Related]
18. Worldwide distribution of HTLV. Tajima K. Jpn J Cancer Res; 1998 Jan; 89(1):inside front cover. PubMed ID: 9510466 [No Abstract] [Full Text] [Related]